Clinical Trial Update: Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer [EARLY_Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update evaluating Genistein in combination with Interleukin-2 for metastatic melanoma or kidney cancer; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Melanoma

Drugs mentioned

• Genistein (genistein)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Northwestern University | Conditions: Kidney Cancer, Melanoma (Skin) | EARLY_Phase 1 | Status: COMPLETED